ClinicalTrials.govpublic full text
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
childhood burkitt lymphoma, childhood central nervous system choriocarcinoma, childhood central nervous system germ cell tumor, childhood central nervous system germinoma, childhood central nervous system mixed germ cell tumor, childhood central nervous system teratoma, childhood central nervous system yolk sac tumor, childhood choroid plexus tumor, childhood craniopharyngioma, childhood diffuse large cell lymphoma, childhood immunoblastic large cell lymphoma, childhood medulloepithelioma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 887256
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.